These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20944801)

  • 21. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
    Morote J; Raventós CX; Lorente JA; Lopez-Pacios MA; Encabo G; de Torres I; Andreu J
    J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
    Walz J; Haese A; Scattoni V; Steuber T; Chun FK; Briganti A; Montorsi F; Graefen M; Huland H; Karakiewicz PI
    Cancer; 2008 Nov; 113(10):2695-703. PubMed ID: 18853417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy.
    Scorilas A; Yu H; Soosaipillai AR; Gregorakis AK; Diamandis EP
    Clin Chim Acta; 2000 Feb; 292(1-2):127-38. PubMed ID: 10686282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of digital rectal examination on serum complexed and free prostate-specific antigen and percentage of free prostate-specific antigen.
    Lechevallier E; Eghazarian C; Ortega JC; Roux F; Coulange C
    Urology; 1999 Nov; 54(5):857-61. PubMed ID: 10565747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen.
    Nixon RG; Lilly JD; Liedtke RJ; Batjer JD
    Arch Pathol Lab Med; 1997 Apr; 121(4):385-91. PubMed ID: 9140308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.
    Törnblom M; Norming U; Adolfsson J; Becker C; Abrahamsson PA; Lilja H; Gustafsson O
    Urology; 1999 May; 53(5):945-50. PubMed ID: 10223488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of prostate-specific antigen-related parameters in discriminating prostate cancer.
    Matsuyama H; Baba Y; Yamakawa G; Yamamoto N; Naito K
    Int J Urol; 2000 Nov; 7(11):409-14. PubMed ID: 11144651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Day to day changes in free and total PSA: significance of biological variation.
    Nixon RG; Wener MH; Smith KM; Parson RE; Blase AB; Brawer MK
    Prostate Cancer Prostatic Dis; 1997 Dec; 1(2):90-96. PubMed ID: 12496922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen.
    Morote J; Lopez M; Encabo G; de Torres IM
    Eur Urol; 2000 May; 37(5):537-40. PubMed ID: 10765091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of first repeat biopsy cancer detection with suspected local stage prostate cancer.
    Fowler JE; Bigler SA; Miles D; Yalkut DA
    J Urol; 2000 Mar; 163(3):813-8. PubMed ID: 10687983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percent free prostate-specific antigen: entering a new era in the detection of prostate cancer.
    Vashi AR; Oesterling JE
    Mayo Clin Proc; 1997 Apr; 72(4):337-44. PubMed ID: 9121181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination.
    Morote J; Raventós CX; Lorente JA; Enbabo G; López M; de Torres I
    Eur Urol; 1999 Aug; 36(2):111-5. PubMed ID: 10420031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between prostate size and percent free prostate-specific antigen in patients with operable prostate cancer.
    Nativ O; Sabo E; Wald M; Halachmi S; Moskovitz B
    Isr Med Assoc J; 2000 Dec; 2(12):889-91. PubMed ID: 11344767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer.
    Partin AW; Brawer MK; Subong EN; Kelley CA; Cox JL; Bruzek DJ; Pannek J; Meyer GE; Chan DW
    Prostate Cancer Prostatic Dis; 1998 Jun; 1(4):197-203. PubMed ID: 12496895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of high-grade prostatic intraepithelial neoplasia on total and percent free serum prostatic-specific antigen.
    Morote J; Raventós CX; Encabo G; López M; de Torres IM
    Eur Urol; 2000 Apr; 37(4):456-9. PubMed ID: 10765077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraindividual variation in total and percent free prostate-specific antigen levels in prostate cancer suspects.
    Kobayashi M; Kurokawa S; Tokue A
    Urol Int; 2005; 74(3):198-202. PubMed ID: 15812203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individual variations of total and percent free serum prostatic specific antigen: could they change the indication of prostatic biopsy?
    Morote J; Encabo G; Lopez M; De Torres IM
    Oncol Rep; 1999; 6(4):887-90. PubMed ID: 10373676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%.
    Khan MA; Sokoll LJ; Chan DW; Mangold LA; Mohr P; Mikolajczyk SD; Linton HJ; Evans CL; Rittenhouse HG; Partin AW
    Urology; 2004 Dec; 64(6):1160-4. PubMed ID: 15596190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age.
    Partin AW; Catalona WJ; Southwick PC; Subong EN; Gasior GH; Chan DW
    Urology; 1996 Dec; 48(6A Suppl):55-61. PubMed ID: 8973701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.